Inverness Counsel’s Incyte INCY Stock Holding History

Inverness Counsel’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,830	Closed	-$330K	–	101
2017 Q3	$330K	Buy	+2,830	New	+$358K	0.02%	84

Other funds holding INCY

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Inverness Counsel's INCY Position: Q4 2017 in Review

Inverness Counsel sold out of Incyte (INCY) in Q4 2017, closing a stake of 2,830 shares — an estimated $330K sold.

Inverness Counsel first reported a position in INCY in Q3 2017 and held it in 1 quarter. The position peaked at $330K in Q3 2017. 503 funds tracked by Wall St. Rank hold INCY as of Q4 2017.

Inverness Counsel reported no remaining Incyte position as of Q4 2017 after selling out during the quarter.
Inverness Counsel sold 2,830 Incyte shares in Q4 2017, an estimated $330K.
Inverness Counsel first reported a position in Incyte in Q3 2017 and held it in 1 quarter.
Inverness Counsel's Incyte position peaked at $330K in Q3 2017.
503 funds tracked by Wall St. Rank held Incyte as of Q4 2017.

Based on Inverness Counsel's 13F filing for Q4 2017, filed 2 Feb 2018.